Skip to main content

Prenatal Diagnosis of Tay-Sachs Disease

  • Protocol
  • First Online:
Prenatal Diagnosis

Part of the book series: Methods in Molecular Biology ((MIMB,volume 1885))

Abstract

Tay-Sachs disease (TSD) is an autosomal recessive lysosomal storage disorder caused by mutations of the HEXA gene resulting in the deficiency of hexosaminidase A (Hex A) and subsequent neuronal accumulation of GM2 gangliosides. Infantile TSD is a devastating and fetal neurodegenerative disease with death before the age of 3–5 years. A small proportion of TSD patients carry milder mutations and may present juvenile or adult onset milder disease. TSD is more prevalent among Ashkenazi Jewish (AJ) individuals and some other genetically isolated populations with carrier frequencies of approximately ~1:27 which is much higher than that of 1:300 in the general population. Carrier screening and prenatal testing for TSD are effective in preventing the birth of affected fetuses greatly diminishing the incidence of TSD. Testing of targeted HEXA mutations by genotyping or sequencing can detect 98% of carriers in AJ individuals; however, the detection rate is much lower for most other ethnic groups. When combined with enzyme analysis, above 98% of carriers can be reliably identified regardless of ethnic background. Multiplex PCR followed by allele-specific primer extension is one method to test for known and common mutations. Sanger sequencing or other sequencing methods are useful to identify private mutations. For prenatal testing, only predefined parental mutations need to be tested. In the event of unknown mutational status or the presence of variants of unknown significance (VUS), enzyme analysis must be performed in conjunction with DNA-based assays to enhance the diagnostic accuracy. Enzymatic assays involve the use of synthetic substrates 4-methylumbelliferyl-N-acetyl-β-glucosamine (4-MUG) and 4-methylumbelliferyl-6-sulfo-2-acetamido-2-deoxy-β-d-glucopyranoside (4-MUGS) to measure the percentage Hex A activity (Hex A%) and specific Hex A activity respectively. These biochemical and molecular tests can be performed in both direct specimens and cultured cells from chorionic villi sampling or amniocentesis.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Moriwaki S, Takashima S, Yoshida H, Kawano N, Goto M (1977) Histological observation of the brain of Tay-Sachs disease with seizure and chronic DPH intoxication—report of an autopsy case. Acta Pathol Jpn 27(3):387–407

    CAS  PubMed  Google Scholar 

  2. Gravel RA, Clarke JTR, Kaback MM, Mahuran D, Sandhoff K, Suzuki K (1995) The GM2 gangliosidoses. In: Scriver CR, Beaudet AL, Sly WS et al (eds) The metabolic and molecular basis of inherited disease, 7th edn. McGraw-Hill, New York, pp 2839–2879

    Google Scholar 

  3. Sandhoff K, Harzer K (2013) Gangliosides and gangliosidoses: principles of molecular and metabolic pathogenesis. J Neurosci 33(25):10195–10208. https://doi.org/10.1523/JNEUROSCI.0822-13.2013

    Article  CAS  PubMed  Google Scholar 

  4. Kaback MM, Desnick RJ (1993) Hexosaminidase A deficiency. In: Pagon RA, Adam MP, Ardinger HH et al (eds) GeneReviews(R). University of Washington, Seattle, Seattle, WA

    Google Scholar 

  5. Zwierz K, Zalewska A, Zoch-Zwierz A (1999) Isoenzymes of N-acetyl-beta-hexosaminidase. Acta Biochim Pol 46(3):739–751

    CAS  PubMed  Google Scholar 

  6. Mahuran DJ, Tsui F, Gravel RA, Lowden JA (1982) Evidence for two dissimilar polypeptide chains in the beta 2 subunit of hexosaminidase. Proc Natl Acad Sci U S A 79(5):1602–1605

    Article  CAS  Google Scholar 

  7. Bayleran J, Hechtman P, Saray W (1984) Synthesis of 4-methylumbelliferyl-beta-D-N-acetylglucosamine-6-sulfate and its use in classification of GM2 gangliosidosis genotypes. Clin Chim Acta 143(2):73–89

    Article  CAS  Google Scholar 

  8. Kronn D, Jansen V, Ostrer H (1998) Carrier screening for cystic fibrosis, Gaucher disease, and Tay-Sachs disease in the Ashkenazi Jewish population: the first 1000 cases at New York University Medical Center, New York, NY. Arch Intern Med 158(7):777–781

    Article  CAS  Google Scholar 

  9. Scott SA, Edelmann L, Liu L, Luo M, Desnick RJ, Kornreich R (2010) Experience with carrier screening and prenatal diagnosis for 16 Ashkenazi Jewish genetic diseases. Hum Mutat 31(11):1240–1250. https://doi.org/10.1002/humu.21327

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Fernandes MJ, Kaplan F, Clow CL, Hechtman P, Scriver CR (1992) Specificity and sensitivity of hexosaminidase assays and DNA analysis for the detection of Tay-Sachs disease gene carriers among Ashkenazic Jews. Genet Epidemiol 9(3):169–175. https://doi.org/10.1002/gepi.1370090303

    Article  CAS  PubMed  Google Scholar 

  11. van Bael M, Natowicz MR, Tomczak J, Grebner EE, Prence EM (1996) Heterozygosity for Tay-Sachs disease in non-Jewish Americans with ancestry from Ireland or Great Britain. J Med Genet 33(10):829–832

    Article  Google Scholar 

  12. De Braekeleer M, Hechtman P, Andermann E, Kaplan F (1992) The French Canadian Tay-Sachs disease deletion mutation: identification of probable founders. Hum Genet 89(1):83–87

    Article  Google Scholar 

  13. Maegawa GH, Stockley T, Tropak M, Banwell B, Blaser S, Kok F, Giugliani R, Mahuran D, Clarke JT (2006) The natural history of juvenile or subacute GM2 gangliosidosis: 21 new cases and literature review of 134 previously reported. Pediatrics 118(5):e1550–e1562. https://doi.org/10.1542/peds.2006-0588

    Article  PubMed  PubMed Central  Google Scholar 

  14. Mahuran DJ (1999) Biochemical consequences of mutations causing the GM2 gangliosidoses. Biochim Biophys Acta 1455(2–3):105–138

    Article  CAS  Google Scholar 

  15. Peleg L, Meltzer F, Karpati M, Goldman B (1995) GM2 gangliosidosis B1 variant: biochemical and molecular characterization of hexosaminidase A. Biochem Mol Med 54(2):126–132

    Article  CAS  Google Scholar 

  16. Cao Z, Natowicz MR, Kaback MM, Lim-Steele JS, Prence EM, Brown D, Chabot T, Triggs-Raine BL (1993) A second mutation associated with apparent beta-hexosaminidase A pseudodeficiency: identification and frequency estimation. Am J Hum Genet 53(6):1198–1205

    CAS  PubMed  PubMed Central  Google Scholar 

  17. Lowden JA, Zuker S, Wilensky AJ, Skomorowski MA (1974) Screening for carriers of Tay-Sachs disease: a community project. Can Med Assoc J 111(3):229–233

    CAS  PubMed  PubMed Central  Google Scholar 

  18. Navon R, Mark Z, Mashiah S, Padeh B (1973) Determination of Tay-Sachs genotypes in pregnant women. Clin Genet 4(3):286–287

    Article  CAS  Google Scholar 

  19. Nitowsky HM, Davis J, Nakagawa S, Fox D (1979) Human hexosaminidase isozymes. IV. Effects of oral contraceptive steroids on serum hexosaminidase activity. Am J Obstet Gynecol 134(6):642–647

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Chunli Yu .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Science+Business Media, LLC, part of Springer Nature

About this protocol

Check for updates. Verify currency and authenticity via CrossMark

Cite this protocol

Zhang, J., Chen, H., Kornreich, R., Yu, C. (2019). Prenatal Diagnosis of Tay-Sachs Disease. In: Levy, B. (eds) Prenatal Diagnosis. Methods in Molecular Biology, vol 1885. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-8889-1_16

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-8889-1_16

  • Published:

  • Publisher Name: Humana Press, New York, NY

  • Print ISBN: 978-1-4939-8887-7

  • Online ISBN: 978-1-4939-8889-1

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics